Novel approaches to the inhibition of mast cells in allergic disease

Clinical and Experimental Allergy

Volumn 38, Issue 5, 2008, Pages 704-708

  Bradding, P ^a,b  

^a UNIVERSITY OF LEICESTER   (United Kingdom)

^b GLENFIELD HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CAMELLIA JAPONICA EXTRACT; FC RECEPTOR; IMMUNOGLOBULIN E; PLANT EXTRACT; POLYGONI CUSPIDATI EXTRACT; PROTEIN KINASE LYN; PROTEIN TYROSINE KINASE; UNCLASSIFIED DRUG;

ALLERGIC DISEASE; CALCIUM TRANSPORT; CELL ACTIVATION; CELL FUNCTION; CELL SECRETION; DEGRANULATION; DRUG EFFECT; EDITORIAL; EXTRACELLULAR CALCIUM; HUMAN; MAST CELL; NONHUMAN; PLANT LEAF; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN STRUCTURE; T LYMPHOCYTE;

ANIMALS; ANTI-ALLERGIC AGENTS; HUMANS; HYPERSENSITIVITY; IMMUNOGLOBULIN E; MAST CELLS; MICE; RECEPTORS, IGE; SIGNAL TRANSDUCTION;

EID: 42249096300     PISSN: 09547894     EISSN: 13652222     Source Type: Journal    
DOI: 10.1111/j.1365-2222.2008.02962.x     Document Type: Editorial

References (63)

1. Asher MI, Montefort S, Bjorksten B et al. Worldwide time trends in the prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and eczema in childhood: ISAAC phases one and three repeat multicountry cross-sectional surveys. Lancet 2006 368 : 733 43.
2. Masoli M, Fabian D, Holt S, Beasley R. The global burden of asthma: executive summary of the GINA Dissemination Committee report. Allergy 2004 59 : 469 78.
3. Bradding P, Walls AF, Holgate ST. The role of the mast cell in the pathophysiology of asthma. J Allergy Clin Immunol 2006 117 : 1277 84.
4. Brightling CE, Bradding P, Symon FA, Holgate ST, Wardlaw AJ, Pavord ID. Mast cell infiltration of airway smooth muscle in asthma. N Engl J Med 2002 346 : 1699 705.
5. Carroll NG, Mutavdzic S, James AL. Increased mast cells and neutrophils in submucosal mucous glands and mucus plugging in patients with asthma. Thorax 2002 57 : 677 82.
6. Gilfillan AM, Tkaczyk C. Integrated signalling pathways for mast-cell activation. Nat Rev Immunol 2006 6 : 218 30.
7. Rivera J, Gilfillan AM. Molecular regulation of mast cell activation. J Allergy Clin Immunol 2006 117 : 1214 25.
8. Duffy SM, Lawley WJ, Conley EC, Bradding P. Resting and activation-dependent ion channels in human mast cells. J Immunol 2001 167 : 4261 70.
9. Kovarova M, Tolar P, Arudchandran R, Draberova L, Rivera J, Draber P. Structure-function analysis of Lyn kinase association with lipid rafts and initiation of early signaling events after Fcepsilon receptor I aggregation. Mol Cell Biol 2001 21 : 8318 28.
10. Saitoh S, Arudchandran R, Manetz TS et al. LAT is essential for Fc(epsilon)RI-mediated mast cell activation. Immunity 2000 12 : 525 35.
11. Saitoh S, Odom S, Gomez G et al. The four distal tyrosines are required for LAT-dependent signaling in FcepsilonRI-mediated mast cell activation. J Exp Med 2003 198 : 831 43.
12. Hoth M, Penner R. Depletion of intracellular calcium stores activates a calcium current in mast cells. Nature 1992 355 : 353 6.
13. 2+ and purified isozymes in washed permeabilized cells. J Biol Chem 1993 268 : 1749 56.
14. Razin E, Szallasi Z, Kazanietz MG, Blumberg PM, Rivera J. Protein kinases C-beta and C-epsilon link the mast cell high-affinity receptor for IgE to the expression of c-fos and c-jun. Proc Natl Acad Sci U S A 1994 91 : 7722 6.
15. Ali K, Bilancio A, Thomas M et al. Essential role for the p110delta phosphoinositide 3-kinase in the allergic response. Nature 2004 431 : 1007 11.
16. Olivera A, Urtz N, Mizugishi K et al. IgE-dependent activation of sphingosine kinases 1 and 2 and secretion of sphingosine 1-phosphate requires Fyn kinase and contributes to mast cell responses. J Biol Chem 2006 281 : 2515 25.
17. Turner H, Cantrell DA. Distinct Ras effector pathways are involved in Fc epsilon R1 regulation of the transcriptional activity of Elk-1 and NFAT in mast cells. J Exp Med 1997 185 : 43 53.
18. Jabril-Cuenod B, Zhang C, Scharenberg AM et al. Syk-dependent phosphorylation of Shc. A potential link between FceRI and the Ras/mitogen-activated protein kinase signaling pathway through SOS and Grb2. J Biol Chem 1996 271 : 16268 72.
19. Church MK, Pao GJ, Holgate ST. Characterization of histamine secretion from mechanically dispersed human lung mast cells: effects of anti-IgE, calcium ionophore A23187, compound 48/80, and basic polypeptides. J Immunol 1982 129 : 2116 21.
20. 2+ responses and secretion in individual RBL-2H3 mucosal mast cells. J Biol Chem 1997 272 : 31225 9.
21. Lewis RS. Calcium oscillations in T-cells: mechanisms and consequences for gene expression. Biochem Soc Trans 2003 31 : 925 9.
22. 2+ influx through receptor-mediated activation of nonspecific cation channels in mast cells. Proc Natl Acad Sci USA 1993 90 : 3068 72.
23. Feske S, Gwack Y, Prakriya M et al. A mutation in Orai1 causes immune deficiency by abrogating CRAC channel function. Nature 2006 441 : 179 85.
24. 2+ entry. Science 2006 312 : 1220 3.
25. Prakriya M, Feske S, Gwack Y, Srikanth S, Rao A, Hogan PG. Orai1 is an essential pore subunit of the CRAC channel. Nature 2006 443 : 230 3.
26. Yeromin AV, Zhang SL, Jiang W, Yu Y, Safrina O, Cahalan MD. Molecular identification of the CRAC channel by altered ion selectivity in a mutant of Orai. Nature 2006 443 : 226 9.
27. Vig M, DeHaven WI, Bird GS et al. Defective mast cell effector functions in mice lacking the CRACM1 pore subunit of store-operated calcium release-activated calcium channels. Nat Immunol 2008 9 : 89 96.
28. Bradding P, Okayama Y, Kambe N, Saito H. Ion channel gene expression in human lung, skin, and cord blood-derived mast cells. J Leukoc Biol 2003 73 : 614 20.
29. Wykes RCE, Lee M, Duffy SM, Yang W, Seward EP, Bradding P. Functional transient receptor potential melastatin 7 (TRPM7) channels are critical for human mast cell survival. J Immunol 2007 179 : 4045 52.
30. 2+ influx and degranulation in human lung mast cells. J Allergy Clin Immunol 2004 114 : 66 72.
31. Dewson GD, Conley EC, Bradding P. Multigene family isoform profiling from blood cell lineages. BMC Genomics 2002 3 : 22.
32. Duffy SM, Leyland ML, Conley EC, Bradding P. Voltage-dependent and calcium-activated ion channels in the human mast cell line HMC-1. J Leukoc Biol 2001 70 : 233 40.
33. Duffy SM, Lawley WJ, Kaur D, Yang W, Bradding P. Inhibition of human mast cell proliferation and survival by tamoxifen in association with ion channel modulation. J Allergy Clin Immunol 2003 112 : 970 7.
34. Ca1 in human mast cells. FASEB J 2005 19 : 1006 8.
35. + channels are required for human lung mast cell migration. Thorax 2006 61 : 880 5.
36. 2A receptor. Eur J Immunol 2007 37 : 1653 62.
37. McCloskey MA, Cahalan MD. G protein control of potassium channel activity in a mast cell line. J Gen Physiol 1990 95 : 205 27.
38. McCloskey MA, Qian YX. Selective expression of potassium channels during mast cell differentiation. J Biol Chem 1994 269 : 14813 9.
39. Kaur D, Berger P, Duffy SM, Brightling CE, Bradding P. Co-cultivation of mast cells and FceRIalpha+ dendritic-like cells from human hip bone marrow. Clin Exp Allergy 2005 35 : 226 33.
40. He S, Aslam A, Gaca MD et al. Inhibitors of tryptase as mast cell-stabilizing agents in the human airways: effects of tryptase and other agonists of proteinase-activated receptor 2 on histamine release. J Pharmacol Exp Ther 2004 309 : 119 26.
41. Columbo M, Horowitz EM, Botana LM et al. The human recombinant c-kit receptor ligand, rhSCF, induces mediator release from human cutaneous mast cells and enhances IgE-dependent mediator release from both skin mast cells and peripheral blood basophils. J Immunol 1992 149 : 599 608.
42. Yanagida M, Fukamachi H, Takei M et al. Interferon-gamma promotes the survival and Fc epsilon RI-mediated histamine release in cultured human mast cells. Immunology 1996 89 : 547 52.
43. Sperr WR, Czerwenka K, Mundigler G et al. Specific activation of human mast cells by the ligand for c-kit: comparison between lung, uterus and heart mast cells. Int Arch Allergy Immunol 1993 102 : 170 5.
44. Coward WR, Okayama Y, Sagara H, Wilson SJ, Holgate ST, Church MK. NF-kappa B and TNF-alpha: a positive autocrine loop in human lung mast cells? J Immunol 2002 169 : 5287 93.
45. Forsythe P, McGarvey LP, Heaney LG, MacMahon J, Ennis M. Adenosine induces histamine release from human bronchoalveolar lavage mast cells. Clin Sci 1999 96 : 349 55.
46. Varadaradjalou S, Feger F, Thieblemont N et al. Toll-like receptor 2 (TLR2) and TLR4 differentially activate human mast cells. Eur J Immunol 2003 33 : 899 906.
47. Kulka M, Alexopoulou L, Flavell RA, Metcalfe DD. Activation of mast cells by double-stranded RNA: evidence for activation through toll-like receptor 3. J Allergy Clin Immunol 2004 114 : 174 82.
48. Benyon RC, Robinson C, Church MK. Differential release of histamine and eicosanoids from human skin mast cells activated by IgE-dependent and non-immunological stimuli. Br J Pharmacol 1989 97 : 898 904.
49. Oskeritzian CA, Zhao W, Min HK et al. Surface CD88 functionally distinguishes the MCTC from the MCT type of human lung mast cell. J Allergy Clin Immunol 2005 115 : 1162 8.
50. Eggleston PA, Kagey-Sobotka A, Schleimer RP, Lichtenstein LM. Interaction between hyperosmolar and IgE-mediated histamine release from basophils and mast cells. Am Rev Respir Dis 1984 130 : 86 91.
51. Okumura S, Kashiwakura J, Tomita H et al. Identification of specific gene expression profiles in human mast cells mediated by toll-like receptor 4 and FceRI. Blood 2003 102 : 2547 54.
52. Cruse G, Kaur D, Yang W, Duffy SM, Brightling CE, Bradding P. Activation of human lung mast cells by monomeric immunoglobulin E. Eur Respir J 2005 25 : 858 63.
53. Cruse G, Cockerill S, Bradding P. IgE alone promotes human lung mast cell survival through the autocrine production of IL-6. BMC Immunol 2008 9 : 2.
54. Brightling CE, Ammit AJ, Kaur D et al. The CXCL10/CXCR3 axis mediates human lung mast cell migration to asthmatic airway smooth muscle. Am J Respir Crit Care Med 2005 171 : 1103 8.
55. Church MK, Hiroi J. Inhibition of IgE-dependent histamine release from human dispersed lung mast cells by anti-allergic drugs and salbutamol. Br J Pharmacol 1987 90 : 421 9.
56. Roberts JA, Bradding P, Britten KM et al. The long-acting beta2-agonist salmeterol xinafoate: effects on airway inflammation in asthma. Eur Respir J 1999 14 : 275 82.
57. Giannini D, Carletti A, Dente FL et al. Tolerance to the protective effect of salmeterol on allergen challenge. Chest 1996 110 : 1452 7.
58. Swystun VA, Gordon JR, Davis EB, Zhang X, Cockcroft DW. Mast cell tryptase release and asthmatic responses to allergen increase with regular use of salbutamol. J Allergy Clin Immunol 2000 106 : 57 64.
59. Lee J-H, Kim J-W, Mun S-H et al. Camellia japonica suppresses IgE-mediated allergic response by the inhibition of Syk kinase activation in mast cells. Clin Exp Allergy 2008 doi :
60. Lim BO, Lee JH, Ko NY et al. Polygoni cuspidati radix inhibits the activation of Syk kinase in mast cells for antiallergic activity. Exp Biol Med 2007 232 : 1425 31.
61. Meltzer EO, Berkowitz RB, Grossbard EB. An intranasal Syk-kinase inhibitor (R112) improves the symptoms of seasonal allergic rhinitis in a park environment. J Allergy Clin Immunol 2005 115 : 791 6.
62. Masuda ES, Schmitz J. Syk inhibitors as treatment for allergic rhinitis. Pulm Pharmacol Ther 2007.
63. Guyer BJ, Shimamoto SR, Bradhurst AL, Grossbard EB, Dreskin SC, Nelson HS. Mast cell inhibitor R112 is well tolerated and affects prostaglandin D2 but not other mediators, symptoms, or nasal volumes in a nasal challenge model of allergic rhinitis. Allergy Asthma Proc 2006 27 : 208 13.